Company: DRTSW
Filing Date: 2025-06-23
Form Type: F-3
Source: 0001213900-25-056744
Chunk: 20

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-06-23
Form: F-3
Chunk 20
---
 to comply with these reporting obligations (or related tax payment obligations) may subject such United
States shareholder to significant monetary penalties and may extend the statute of limitations with respect to such United States shareholder’s
U.S. federal income tax return for the year for which reporting (or payment of tax) was due. We cannot provide any assurances that it
will assist U.S. Holders in determining whether we or any of our subsidiaries are treated as a controlled foreign corporation for U.S.
federal income tax purposes or whether any U.S. Holder is treated as a United States shareholder with respect to any of such controlled
foreign corporations or furnish to any holder information that may be necessary to comply with reporting and tax paying obligations if
we, or any of our subsidiaries, are treated as a controlled foreign corporation for U.S. federal income tax purposes.

<div align='center'>7

CAPITALIZATION</div>

The following table sets forth
our cash and cash equivalents and total capitalization on an actual basis as of March 31, 2025. The information in this table should be
read in conjunction with the financial statements and notes thereto and other financial information included in this prospectus, any prospectus
supplement or incorporated by reference in this prospectus. Our historical results do not necessarily indicate our expected results for
any future periods.

|                                                                                                            |     | As of          
 March 31,      
 2025           |          |   |
|:-----------------------------------------------------------------------------------------------------------|:----|:---------------|---------:|:--|
|                                                                                                            |     | -in thousands, 
 except         
 share figures  |          |   |
| Cash and cash equivalents                                                                                  |     | $              |    5,019 |   |
| Debt:                                                                                                      |     |                |          |   |
| Long-term loan                                                                                             |     | $              |    5,472 |   |
| Warrant liability                                                                                          |     |                |    3,545 |   |
| Operating lease liabilities                                                                                |     |                |    5,820 |   |
| Total long-term debt                                                                                       |     |                |   14,837 |   |
| Ordinary shares, no par value; 362,116,800 shares authorized; 70,511,475 issued and outstanding, actual(1) |     |                |        — |   |
| Additional paid-in capital                                                                                 |     |                |  212,525 |   |
| Accumulated deficit                                                                                        |     |